BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7972221)

  • 21. Neuron-specific hel-N1 and HuD as novel molecular markers of neuroblastoma: a correlation of HuD messenger RNA levels with favorable prognostic features.
    Ball NS; King PH
    Clin Cancer Res; 1997 Oct; 3(10):1859-65. PubMed ID: 9815574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
    Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
    Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroblastoma in the first year of life: clinical and biologic factors influencing outcome.
    Grosfeld JL; Rescorla FJ; West KW; Goldman J
    Semin Pediatr Surg; 1993 Feb; 2(1):37-46. PubMed ID: 8062021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of n-myc gene amplification in neuroblastoma by comparative, in situ,and real-time polymerase chain reaction.
    Melegh Z; Bálint I; Tóth E; Csernák E; Szentirmay Z; Nagy K
    Pediatr Pathol Mol Med; 2003; 22(3):213-22. PubMed ID: 12746172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unfavorable DNA ploidy and Ha-ras p21 findings in neuroblastomas detected through mass screening.
    Kusafuka T; Nagahara N; Oue T; Imura K; Nakamura T; Kobayashi Y; Komoto Y; Fukuzawa M; Okada A; Nakayama M
    Cancer; 1995 Aug; 76(4):695-9. PubMed ID: 8625168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes.
    Pechoux C; Chardonnet Y; Chignol MC; Noël P
    Histol Histopathol; 1994 Jan; 9(1):35-44. PubMed ID: 8003818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [CD44 expression: a new prognostic factor in neuroblastoma].
    Combaret V; Lasset C; Bouvier R; Frappaz D; Thiesse P; Rebillard AC; Philip T; Favrot MC
    Bull Cancer; 1995 Jan; 82(2):131-6. PubMed ID: 10846530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-myc gene amplification and other prognosis-associated factors in neuroblastoma.
    Hiyama E; Yokoyama T; Ichikawa T; Ishii T; Hiyama K
    J Pediatr Surg; 1990 Oct; 25(10):1095-9. PubMed ID: 2262866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD44--a new prognostic marker for neuroblastoma.
    Favrot MC; Combaret V; Lasset C
    N Engl J Med; 1993 Dec; 329(26):1965. PubMed ID: 7504209
    [No Abstract]   [Full Text] [Related]  

  • 30. [Abdominal neuroblastoma. An analysis of 48 cases].
    Carlsen NL; Nielsen OH
    Ugeskr Laeger; 1980 Nov; 142(45):2972-5. PubMed ID: 7466941
    [No Abstract]   [Full Text] [Related]  

  • 31. Significance of plasma neuropeptide Y (NPY) in diagnosis and prognosis of neuroblastoma.
    Hayashi Y; Ohi R; Sone M; Takahashi K; Mouri T; Watanabe T; Yaoita S; Nakamura M
    Prog Clin Biol Res; 1991; 366():359-65. PubMed ID: 2068151
    [No Abstract]   [Full Text] [Related]  

  • 32. [Neuroblastoma in childhood as a biological problem].
    Stasek V; Jakoubková J; Koutecký J; Bubeník J
    Vnitr Lek; 1974 Jul; 20(6):609-12. PubMed ID: 4844795
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical significance of anti human N-myc protein antibody assay as a tumor marker].
    Nakagawa C; Tsukahara T; Shimatake H
    Nihon Rinsho; 1990 Feb; 48 Suppl():942-5. PubMed ID: 2192178
    [No Abstract]   [Full Text] [Related]  

  • 34. Neuroblastoma, clinical study of 55 cases.
    Yata J; Aikawa M; Ohmi K; Yanagisawa M; Furukawa T
    Paediatr Univ Tokyo; 1966 Dec; 13():34-42. PubMed ID: 5979954
    [No Abstract]   [Full Text] [Related]  

  • 35. [Neuroblastoma].
    Nielsen OH; Carlsen NL; Hertz H; Pedersen KD
    Ugeskr Laeger; 1980 Nov; 142(45):2968-72. PubMed ID: 7466940
    [No Abstract]   [Full Text] [Related]  

  • 36. Neuroblastoma.
    Hayes FA; Green AA
    Pediatr Ann; 1983 May; 12(5):366-7, 370-3. PubMed ID: 6877889
    [No Abstract]   [Full Text] [Related]  

  • 37. Neuroblastoma, a study of presenting signs and symptoms.
    Davis LA; Kmetz DR; Johnson WW; Davis LT
    J Ky Med Assoc; 1970 Nov; 68(11):731-2 passim. PubMed ID: 5485378
    [No Abstract]   [Full Text] [Related]  

  • 38. [Deceptive onsets of sympathoblastomas].
    Orsini A; Perrimond H; Vo Van L; Pierron H; Bernard P
    Pediatrie; 1966 Sep; 21(6):714-5. PubMed ID: 5954602
    [No Abstract]   [Full Text] [Related]  

  • 39. Proceedings: Neuroblastoma: a retrospective study of 247 cases.
    Keeling JW
    Arch Dis Child; 1974 Jan; 49(1):74. PubMed ID: 4818100
    [No Abstract]   [Full Text] [Related]  

  • 40. [Deceiving onsets of sympathoblastomas].
    Orsini A; Perrimond H; Vo Van L; Pierron H
    Mars Med; 1966; 103(6):473-80. PubMed ID: 5913946
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.